Literature DB >> 11689634

Restoration of function of carboxy-terminally truncated pseudorabies virus glycoprotein B by point mutations in the ectodomain.

R Nixdorf1, B G Klupp, T C Mettenleiter.   

Abstract

Glycoprotein B (gB) of pseudorabies virus (PrV) is essential for virus entry into target cells and direct viral cell-to-cell spread. Recently, we described a carboxy-terminally truncated derivative of PrV gB, gB-007, which was inefficiently incorporated into virions, was unable to complement infectivity, but was fully capable of restoring direct viral cell-to-cell spread of gB-negative PrV (R. Nixdorf, B. G. Klupp, and T. C. Mettenleiter, J. Virol. 74:7137-7145, 2000). Since recombinant PrV-007, which expresses gB-007 instead of wild-type gB, was able to spread directly from cell to cell, we attempted to obtain compensatory mutations leading to restoration of the entry defect by performing serial passages in cell culture. This procedure has previously been used to successfully restore entry defects in gD- or gL-deficient PrV mutants. From an initial titer of 100 PFU per ml in the supernatant, titers increased, reaching wild-type levels of up to 10(7) PFU after ca. 20 passages. One single-plaque isolate of the passaged mutant, designated PrV-007Pass, was further characterized. PrV-007Pass gB was efficiently incorporated into the viral envelope and restored infectivity to a gB-negative PrV mutant, PrV-gB(-). Interestingly, localization of PrV-007Pass gB in the plasma membrane was similar to that of PrV-007. In contrast, wild-type gB is mainly found in intracellular vesicles. Marker rescue experiments and trans-complementation assays demonstrated the presence of compensatory mutations within the gB gene of PrV-007Pass. DNA sequencing revealed two point mutations in the gB open reading frame of PrV-007Pass, resulting in amino acid substitutions at positions 305 and 744 of gB, both of which are required for compensation of the defect in PrV-007. Our data again demonstrate the power of reversion analysis of herpesviruses and suggest that cytosolic and ectodomains play a role in incorporation of gB into virions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689634      PMCID: PMC114739          DOI: 10.1128/JVI.75.23.11526-11533.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Bovine herpesvirus 1 requires glycoprotein H for infectivity and direct spreading and glycoproteins gH(W450) and gB for glycoprotein D-independent cell-to-cell spread.

Authors:  C Schr der; G M Keil
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

2.  Location of the structural gene of pseudorabies virus glycoprotein complex gII.

Authors:  T C Mettenleiter; N Lukàcs; H J Thiel; C Schreurs; H J Rziha
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

3.  Processing of pseudorabies virus glycoprotein gII.

Authors:  U Wölfer; V Kruft; D Sawitzky; H Hampl; B Wittmann-Liebold; K O Habermehl
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus.

Authors:  T C Mettenleiter; L Zsak; F Zuckermann; N Sugg; H Kern; T Ben-Porat
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

5.  Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells.

Authors:  D C Johnson; R L Burke; T Gregory
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Cross-linking of glycoprotein oligomers during herpes simplex virus type 1 entry.

Authors:  C G Handler; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Role of the cytoplasmic tails of pseudorabies virus glycoproteins B, E and M in intracellular localization and virion incorporation.

Authors:  Ralf Nixdorf; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Gen Virol       Date:  2001-01       Impact factor: 3.891

8.  Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains.

Authors:  R S Tirabassi; R A Townley; M G Eldridge; L W Enquist
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration.

Authors:  I Rauh; T C Mettenleiter
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Sequence and expression of the glycoprotein gH gene of pseudorabies virus.

Authors:  B G Klupp; T C Mettenleiter
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

View more
  5 in total

1.  Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

2.  Virion-incorporated glycoprotein B mediates transneuronal spread of pseudorabies virus.

Authors:  Dusica Curanovic; Lynn W Enquist
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

3.  The pseudorabies virus US3 protein is a component of primary and of mature virions.

Authors:  Harald Granzow; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Pseudorabies virus UL3 gene codes for a nuclear protein which is dispensable for viral replication.

Authors:  Barbara G Klupp; Harald Granzow; Walter Fuchs; Egbert Mundt; Thomas C Mettenleiter
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

5.  In Vitro Viral Evolution Identifies a Critical Residue in the Alphaherpesvirus Fusion Glycoprotein B Ectodomain That Controls gH/gL-Independent Entry.

Authors:  Melina Vallbracht; Henriette Lötzsch; Barbara G Klupp; Walter Fuchs; Benjamin Vollmer; Kay Grünewald; Marija Backovic; Felix A Rey; Thomas C Mettenleiter
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.